{
  "actions": [
    {
      "acted_at": "2009-03-17",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2009-03-17",
      "action_code": "",
      "committees": [
        "SSHR"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s613-111",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "Senate Health, Education, Labor, and Pensions",
      "committee_id": "SSHR"
    }
  ],
  "congress": "111",
  "cosponsors": [],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2009-03-17",
  "number": "613",
  "official_title": "A bill to prohibit the use of Federal funds to approve certain biologics license applications by the Food and Drug Administration.",
  "popular_title": null,
  "related_bills": [],
  "short_title": null,
  "sponsor": {
    "bioguide_id": "B000953",
    "district": null,
    "name": "Brownback, Sam",
    "state": "KS",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2009-03-17",
  "subjects": [
    "Department of Health and Human Services",
    "Drug safety, medical device, and laboratory regulation",
    "Executive agency funding and structure",
    "Food and Drug Administration (FDA)",
    "Government studies and investigations",
    "Hazardous wastes and toxic substances",
    "Health",
    "Iran",
    "Licensing and registrations",
    "Middle East",
    "Sanctions",
    "Trade restrictions"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in Senate",
    "asOf": "2009-03-17",
    "date": "2009-04-24T16:38:04Z",
    "text": "Prohibits the use of funds by the Food and Drug Administration (FDA) to process a biologics license application for any biologic product that is, bears, or contains an agent or toxin listed in federal regulations as dangerous to life, property, or the environment and that has been marketed, sold, or distributed to the Islamic Republic of Iran by an entity under investigation for potential violations of the Iran Sanctions Act of 1996."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to prohibit the use of Federal funds to approve certain biologics license applications by the Food and Drug Administration.",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to prohibit the use of Federal funds to approve certain biologics license applications by the Food and Drug Administration.",
      "type": "official"
    }
  ],
  "updated_at": "2023-01-11T13:19:43Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/111/s/BILLSTATUS-111s613.xml"
}